Edwards Lifesciences (EW) free cash flow

Free cash flow · fiscal 2025
$1.34B

Edwards Lifesciences (EW) generated free cash flow of $1.34B in fiscal 2025 (the year ended December 31, 2025). That is 413.7% higher than the $259.90M of fiscal 2024. Figures as of 18 Nov 2026, 12:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.34B
Change on fiscal 2024
+413.7%
Growth, 5 years
+15.6% a year
Growth, 10 years
+11.6% a year
Highest on record
$1.41Bfiscal 2021
Lowest on record
$101.30Mfiscal 2009
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Edwards Lifesciences free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 15.6% a year; over ten years the rate was 11.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.41B in fiscal 2021 and the lowest $101.30M in fiscal 2009.

History · 18 fiscal years

Free cash flow by fiscal year

Edwards Lifesciences free cash flow, year by year

Edwards Lifesciences (EW) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.34B 413.7% up
2024$259.90M 58.7% down
2023$629.50M 34.0% down
2022$953.40M 32.2% down
2021$1.41B 117.3% up
2020$647.30M 30.3% down
2019$928.50M 35.0% up
2018$688.00M 17.4% down
2017$832.60M 57.6% up
2016$528.30M 18.2% up
2015$447.00M 52.4% down
2014$939.40M 158.3% up
2013$363.70M 43.7% up
2012$253.10M 9.3% up
2011$231.60M 22.2% up
2010$189.60M 87.2% up
2009$101.30M 1.3% down
2008$102.60M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Edwards Lifesciences and comparable companies
CompanyFree cash flowFiscal year
Boston Scientific BSX$3.40B2025
Cardinal Health CAH$4.53B2026
argenx ARGX$573.51M2025
Edwards Lifesciences EW$1.34B2025
Becton, Dickinson BDX$2.67B2025
IDEXX Laboratories IDXX$1.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EW

Edwards Lifesciences, figure by figure

Edwards Lifesciences (EW) overview: price, valuation and scorecardAll health care companies by market value

Edwards Lifesciences free cash flow: questions and answers

What is Edwards Lifesciences's free cash flow?

Edwards Lifesciences (EW) generated free cash flow of $1.34B in fiscal 2025 (the year ended December 31, 2025). That is 413.7% higher than the $259.90M of fiscal 2024.

What is the growth rate of Edwards Lifesciences's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 15.6% a year; over ten years the rate was 11.6% a year.

What are the highest and lowest free cash flow figures on record for Edwards Lifesciences?

Across the 18 fiscal years on record (2008–2025), the highest was $1.41B in fiscal 2021 and the lowest $101.30M in fiscal 2009.

How is Edwards Lifesciences's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Edwards Lifesciences it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edwards Lifesciences (EW) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/EW/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.